Accès ouvert
2026
article
OpenAlex
Yanping Su, Hongfei Hu, Liyan Jiang, Ruolei Ye et autres
The clinical presentation of acute myocarditis (AM) often overlaps with that of acute myocardial infarction (AMI), posing a diagnostic challenge. This study aimed to develop and evaluate an interpretable machine-learning strategy integrating cardiac magnetic resonance (CMR)-derived myocardial strain and clinical variables to …
cn
(code pays fourni par la source)
2026
article
OpenAlex
Yechao Huang, Joe Sarah Luciny, Yumin Hu, Dengfa Yang et autres
cn
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Zhaozhi Li, Jiaoyang Li, Yun Ouyang, Liyan Jiang et autres
Purpose: Growth differentiation factor 3 (GDF3), a TGFβ superfamily cytokine, has been linked to visceral adipose proliferation and adiposity in animal studies. However, the relationship between circulating GDF3 levels and visceral adiposity in humans remains unclear. This study aimed to assess the …
cn
(code pays fourni par la source)
2025
article
OpenAlex
Zhengbo Song, Ziming Li, Yiping Zhang, Pingli Wang et autres
cn, hk
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Yang Xu, Liyan Jiang, Shasha Yang
Against the educational backdrop of deep interdisciplinary integration and empowering new models for cultivating composite talents, this innovative training experiment focuses on the hot interdisciplinary field of molecular archaeology, targeting the fragmented state of paleontological remains that do not have morphological identification …
cn
(code pays fourni par la source)
2025
article
OpenAlex
Pasi A. Jänne, David Planchard, Kunihiko Kobayashi, James Chih‐Hsin Yang et autres
BackgroundThe primary analysis of this trial showed that first-line treatment with osimertinib plus chemotherapy with a platinum-based agent and pemetrexed led to significantly longer progression-free survival than osimertinib monotherapy among patients with epidermal growth factor receptor (EGFR)–mutated advanced non–small-cell lung cancer (NSCLC). …
us, fr, jp, tw, cn, pe, kr, in, ru, br, cz, gb, ca, sg, es, au
(code pays fourni par la source)
2025
article
OpenAlex
Zeliu Du, H. Hu, Jie Mei, Ye Feng et autres
cn, ca, us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Xianhui Cheng, Wenjing Yu, Dongxue Wang, Liyan Jiang et autres
Exosomes are 40-160 nm vesicular nano-bodies secreted by most cells that carry large amounts of biologically active substances originating from the parent cell. Proteins in exosomes are protected by phospholipid bilayer membranes that protect them from degradation by enzymes within body fluids. …
cn, nl
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Jiayuan Peng, Fang Hu, Yuxiao Niu, Xin Lü et autres
Abstract RATIONALE: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are the standard treatment for advanced non-small cell lung cancer (NSCLC) patients harboring sensitive EGFR mutations. Traditional imaging methods are used to evaluate the response to antitumor therapy by measuring tumor size …
cn
(code pays fourni par la source)
Accès ouvert
2025
erratum
OpenAlex
Liyan Jiang, Xiaoqi Tang, Jing Lü, Gang He et autres
cn, us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Pasi A. Jänne, David Planchard, Kunihiko Kobayashi, Ying Cheng et autres
Plain Language SummaryWhat was the purpose of the FLAURA2 study?This is a summary of results from the FLAURA2 clinical study in patients with EGFR-mutated, advanced non-small cell lung cancer (NSCLC). The results were published in full in 2023.NSCLC represents 85% of lung …
us, fr, jp, cn, au, pe, ru, tw, th, ca, gb
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Xiaobei Guo, Xiaoyan Liu, Chao Guo, Qian Miao et autres
Adjuvant osimertinib administered over a 3-year period in patients diagnosed with stage IB-IIIA non-small cell lung cancer (NSCLC) and epidermal growth factor receptor (EGFR) mutations has not only shown improvement in event-free survival but also demonstrated a prolonged overall survival (OS), leading …
cn
(code pays fourni par la source)